Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study
Authors:
- On Behalf of the Handheld-BNP Research NetworkONOn Behalf of the Handheld-BNP Research Network
- Christiane E. AngermannCAChristiane E. Angermann
- 15 November 2017
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 107 (2) , 95-107
Abstract
Patients with suspected heart failure (HF) often present first to general practitioners (GPs). Timely and accurate HF diagnosis and reliable prognostic information have remained unmet goals in primary care, where patient evaluation often relies on clinical assessment only. The Handheld-BNP program investigates whether additional use of portable echocardiography (ECHO) and point-of-care determination of B-type natriuretic peptide (BNP) improves the accuracy of HF diagnosis and aids risk prediction in primary care.Keywords
Funding Information
- Federal Ministry of Education and Research (BMBF) Germany (01GI0205, 01GI1202A)
This publication has 74 references indexed in Scilit:
- The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and designBMC Cardiovascular Disorders, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetesDiabetologia, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Discriminating Between Cardiac and Pulmonary Dysfunction in the General Population With Dyspnea by Plasma Pro-B-Type Natriuretic PeptideJACC, 2007
- Clinical epidemiology of heart failureHeart, 2007
- Evidence of bias and variation in diagnostic accuracy studiesCanadian Medical Association Journal, 2006
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Evidence of inadequate investigation and treatment of patients with heart failure.Heart, 1994
- Physician practice in the management of congestive heart failureJACC, 1986